BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30717767)

  • 1. Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds.
    Teng F; Li J; Cui T; Xu K; Guo L; Gao Q; Feng G; Chen C; Han D; Zhou Q; Li W
    Genome Biol; 2019 Feb; 20(1):15. PubMed ID: 30717767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized protocols for the characterization of Cas12a activities.
    Martin L; Rostami S; Rajan R
    Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the scope of plant genome engineering with Cas12a orthologs and highly multiplexable editing systems.
    Zhang Y; Ren Q; Tang X; Liu S; Malzahn AA; Zhou J; Wang J; Yin D; Pan C; Yuan M; Huang L; Yang H; Zhao Y; Fang Q; Zheng X; Tian L; Cheng Y; Le Y; McCoy B; Franklin L; Selengut JD; Mount SM; Que Q; Zhang Y; Qi Y
    Nat Commun; 2021 Mar; 12(1):1944. PubMed ID: 33782402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing noncanonical crRNA for highly efficient genome editing.
    Xun G; Zhu Z; Singh N; Lu J; Jain PK; Zhao H
    Nat Commun; 2024 May; 15(1):3823. PubMed ID: 38714643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly efficient and safe genome editing by CRISPR-Cas12a using CRISPR RNA with a ribosyl-2'-O-methylated uridinylate-rich 3'-overhang in mouse zygotes.
    Ha DI; Lee JM; Lee NE; Kim D; Ko JH; Kim YS
    Exp Mol Med; 2020 Nov; 52(11):1823-1830. PubMed ID: 33162553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a.
    Liu W; Tang D; Wang H; Lian J; Huang L; Xu Z
    Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):8911-8922. PubMed ID: 31583448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient multiplex CRISPR/Cpf1 (Cas12a) genome editing system in Aspergillus aculeatus TBRC 277.
    Abdulrachman D; Champreda V; Eurwilaichitr L; Chantasingh D; Pootanakit K
    J Biotechnol; 2022 Aug; 355():53-64. PubMed ID: 35788357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates.
    Ling X; Chang L; Chen H; Gao X; Yin J; Zuo Y; Huang Y; Zhang B; Hu J; Liu T
    Mol Cell; 2021 Nov; 81(22):4747-4756.e7. PubMed ID: 34648747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
    Murugan K; Seetharam AS; Severin AJ; Sashital DG
    J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing.
    Wang L; Wang H; Liu H; Zhao Q; Liu B; Wang L; Zhang J; Zhu J; Bao R; Luo Y
    Biotechnol Bioeng; 2019 Jun; 116(6):1463-1474. PubMed ID: 30730047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Profiling of Cas12a Orthologues and Engineered Variants for Enhanced Genome Editing Activity.
    Zhu D; Wang J; Yang D; Xi J; Li J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing noncanonical crRNAs to improve functionality of Cas12a orthologs.
    Nguyen LT; Macaluso NC; Rakestraw NR; Carman DR; Pizzano BLM; Hautamaki RC; Rananaware SR; Roberts IE; Jain PK
    Cell Rep; 2024 Feb; 43(2):113777. PubMed ID: 38358883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.
    Huang H; Huang G; Tan Z; Hu Y; Shan L; Zhou J; Zhang X; Ma S; Lv W; Huang T; Liu Y; Wang D; Zhao X; Lin Y; Rong Z
    BMC Biol; 2022 Apr; 20(1):91. PubMed ID: 35468792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved genome editing by an engineered CRISPR-Cas12a.
    Ma E; Chen K; Shi H; Stahl EC; Adler B; Trinidad M; Liu J; Zhou K; Ye J; Doudna JA
    Nucleic Acids Res; 2022 Dec; 50(22):12689-12701. PubMed ID: 36537251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Split CRISPR-Cpf1 Platform for Inducible Gene Activation.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2023; 2577():229-240. PubMed ID: 36173577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA.
    Gao Z; Fan M; Das AT; Herrera-Carrillo E; Berkhout B
    Nucleic Acids Res; 2020 Jun; 48(10):5527-5539. PubMed ID: 32282899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system.
    Wang H; Zhou J; Lei J; Mo G; Wu Y; Liu H; Pang Z; Du M; Zhou Z; Paek C; Sun Z; Chen Y; Wang Y; Chen P; Yin L
    PLoS Biol; 2024 May; 22(5):e3002619. PubMed ID: 38814985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array.
    Zetsche B; Heidenreich M; Mohanraju P; Fedorova I; Kneppers J; DeGennaro EM; Winblad N; Choudhury SR; Abudayyeh OO; Gootenberg JS; Wu WY; Scott DA; Severinov K; van der Oost J; Zhang F
    Nat Biotechnol; 2017 Jan; 35(1):31-34. PubMed ID: 27918548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances of Cas12a applications in bacteria.
    Meliawati M; Schilling C; Schmid J
    Appl Microbiol Biotechnol; 2021 Apr; 105(8):2981-2990. PubMed ID: 33754170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.